by | Jan 13, 2026 | Brestoff Parker, Jonathan, Diamond, Michael, Jia, Wentong
— Published date: 1/14/2026
Value Proposition: Novel target for therapeutic treatment of obesity and related metabolic diseases.
Technology Description
Researchers at Washington University in St. Louis have developed a therapeutic targeting MXRA8 to treat obesity and associated metabolic disea…
by | Jan 5, 2026 | Dai, Yifan, Pappu, Rohit
— Published date: 1/6/2025
Value Proposition: Directed evolution of synthetic intrinsically disordered proteins for condensate editing.
Technology Description
Researchers at Washington University in St. Louis have developed a directed evolution method and selection strategies to enable the evolut…
by | Jan 5, 2026 | Boon, Adrianus "Jacco", Dai, Yanan, Fremont, Daved, Harastani, Houda
— Published date: 1/6/2025
Value Proposition: Stabilization of glycoprotein of Bourbon Virus (BRBV) and related thogotoviruses as a key target for vaccine and antiviral development.
Technology Description
Researchers at Washington University in St. Louis have determined the pre-fusion structure…
by | Sep 17, 2025 | Fremont, Daved, Nelson, Christopher, Teitelbaum, Steven, Warren, Julia
— Published date: 9/18/2025
Value Proposition: Single chain RANK ligand that can selectively inhibit pathological bone loss.
Technology Description
Researchers at Washington University in St. Louis have developed a genetically engineered mutant RANKL protein that prevents bone loss by selective…
by | Jun 3, 2025 | Feldman, Mario, Jana, Biswanath, Pardue, Evan, Sartorio, Mariana
— Published Date: 6/3/2025
Value Proposition: System that employs gut microbe strains engineered with therapeutic enzymes to treat chronic gut conditions.
Technology Description
Researchers at Washington University in St. Louis have developed a hypervesiculating Bacteroides theatiotaomicron (Bt) …